Publikationer av / inom följande

BARFOT

2006-09-11

Association of HLA-C3 and smoking with vasculitis in patients with rheumatoid arthritis.

Turesson C, Schaid DJ, Weyand CM, Jacobsson LT, Goronzy JJ, Petersson IF, Dechant SA, Nyähll-Wåhlin BM, Truedsson L, Sturfelt G, Matteson EL.Arthritis Rheum. 2006 Sep;54(9):2776-83. doi: 10.1002/art.22057.PMID: 16947780

2006-08-25

Study of the role of a functional polymorphism of MHC2TA in rheumatoid arthritis in three ethnically different populations.

Orozco G, Robledo G, Linga Reddy MV, García A, Pascual-Salcedo D, Balsa A, González-Gay MA, Eimon A, Paira S, Scherbarth HR, Pons-Estel BA, Petersson IF, Alarcón-Riquelme M, Martín J.Rheumatology (Oxford). 2006 Nov;45(11):1442-4. doi: 10.1093/rheumatology/kel272. Epub 2006 Aug 25.PMID: 16935917

2006-02-11

Svensson B, Hafström I. Evidens för behandling med glucocorticoider i låg dos vid tidig reumatoid artrit. Läkartidningen 2006;103:3704-9

2005-11-10

Low-dose prednisolone in addition to the initial disease-modifying antirheumatic drug in patients with early active rheumatoid arthritis reduces joint destruction and increases the remission rate: a two-year randomized trial.

Svensson B, Boonen A, Albertsson K, van der Heijde D, Keller C, Hafström I.Arthritis Rheum. 2005 Nov;52(11):3360-70. doi: 10.1002/art.21298.PMID: 16255010 Clinical Trial.

2005-10-11

The impact of HLA-DRB1 genes on extra-articular disease manifestations in rheumatoid arthritis.

Turesson C, Schaid DJ, Weyand CM, Jacobsson LT, Goronzy JJ, Petersson IF, Sturfelt G, Nyhäll-Wåhlin BM, Truedsson L, Dechant SA, Matteson EL.Arthritis Res Ther. 2005;7(6):R1386-93. doi: 10.1186/ar1837. Epub 2005 Oct 11.PMID: 16277691 Free PMC article.

2005-09-15

Smoking is a strong risk factor for rheumatoid nodules in early rheumatoid arthritis.

Nyhäll-Wåhlin BM, Jacobsson LT, Petersson IF, Turesson C; BARFOT study group.Ann Rheum Dis. 2006 May;65(5):601-6. doi: 10.1136/ard.2005.039172. Epub 2005 Sep 15.PMID: 16166104 Free PMC article.

2004-09-10

Prediction of radiological outcome in early rheumatoid arthritis in clinical practice: role of antibodies to citrullinated peptides (anti-CCP).

Forslind K, Ahlmén M, Eberhardt K, Hafström I, Svensson B; BARFOT Study Group.Ann Rheum Dis. 2004 Sep;63(9):1090-5. doi: 10.1136/ard.2003.014233.PMID: 15308518 Free PMC article.

2004-03-18

Antikroppar mot citrullinerade proteiner/peptider – ett genombrott inom reumatologisk diagnostik.
Rönnelid J, Klareskog L , Skogh T och Svensson B.
Review. Läkartidningen 2004:50;4092-96

Cookie-samtycke med Real Cookie Banner